
Gabriel Schuler, PhD
CEO & Co-Founder
TCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGA
TCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGA
ATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATC
GATCGA
TCGAT
CGAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCGA GATC
GAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCGAUCG ATCG
GAUCGAU TCGA
CGAUC CGAT
AUCG GATC
GAUC UCGAU CGAUCGAUCGAUCGAUCGAUC AUCG UCGA ATCG
ATCGAT CGATC GATCGATCGATCGATCGATCGAT TCGA CGAU TCGA
UCGAUCG GAUCG AUCG CGAUCG CGAU GAUC CGAT
CGATCGATC ATCGA TCGA TCGAT GATC AUCG GATC
GAUCGAUCGA UCGAU CGAU CGAUC AUCG UCGA ATCG
ATCG CGATCG CGATC GATC GATCG TCGA CGAU TCGA
UCGA AUCGAU GAUCG AUCG CGAUCG CGAU GAUC CGAT
CGAT GATCGA ATCGA TCGATCGATCGATCGATCGATCG GATC AUCG GATC
GAUC UCGAUC UCGAU CGAUCGAUCGAUCGAUCGAUCGA AUCG UCGA ATCG
ATCG ATCGA CGATC GATCG ATCGATC TCGA CGAU TCGA
UCGA CGAUCG GAUCG AUCG AUCGA CGAU GAUC CGAT
CGAT ATCGAT ATCGA TCGA CGATC GATC AUCG GATC
GAUC GAUCGAUCGAU CGAU GAUCG AUCG UCGA ATCG
ATCG TCGATCGATC GATC ATCG TCGA CGAU TC
UCGA AUCGAUCG AUCG GAUCGA CGAU GAUC
CGAT CGATCGA TCGATCGATCGATCGATCGATCGA GATC AUCG
GAUC UCGAU CGAUCGAUCGAUCGAUCGAUC AUCG UC
NiagaraBio
We’re engineering customizable molecular detection kits at the speed of AI.
MULTIPLEX MOLECULAR DETECTION · POINT-OF-NEED TESTING · CRISPR DIAGNOSTICS
TICK-BORNE PATHOGEN TESTING
Lyme disease is a growing threat as blacklegged ticks expand into new regions. We’re developing a rapid, point-of-care test for Borrelia burgdorferi, the primary cause of Lyme disease in the U.S. The kit tests removed ticks on site, without mailing specimens to a laboratory. Our goal is to empower outdoor lovers to have informed conversations with their doctors about exposure and symptoms, while supporting antibiotic stewardship through appropriate antibiotic use guided by clinical assessment.
Protein engineering. Computational design. Physical hardware.
Three disciplines working toward a test people can use.

CEO & Co-Founder

Co-Founder

Co-Founder
Buffalo Niagara has a long tradition of turning scientific ambition into practical progress. We’re proud to build NiagaraBio here.
The Adams hydroelectric power plant opened in 1895 and began supplying electricity to Buffalo in 1896, helping power a new era of American industry.
Founded in Buffalo in 1898, Roswell Park became the world’s first institution devoted exclusively to cancer research.
Buffalo’s 1901 Pan-American Exposition showcased emerging technologies, including X-ray imaging and electric lighting powered by Niagara Falls.
In 1960, Buffalo researchers designed and tested the first commercially produced implantable pacemaker. In 1972, Buffalo VA helped evaluate nuclear-powered pacemakers.
Buffalo volunteers supplied much of the DNA used for the original human genome sequence. Roswell Park researchers prepared that DNA for sequencing, contributing to a global scientific effort.
Proudly made in the Buffalo Niagara region. American made.
PREPRINT · 21 OCTOBER 2026 · VERSION 1
Schuler, T. M., Schuler, G. A., & Zobel, A. S. R. (2026). Locally deployed AI agents for CRISPR guide discovery from outbreak reports. bioRxiv [Preprint]. doi:10.64898/2026.10.20.760479
LET’S BUILD WHAT COMES NEXT.
Connect with NiagaraBio about our development plans and investment opportunities.
contact@niagarabio.com
NiagaraBio — website directory
IN DEVELOPMENT · ENGINEERING THE NEXT GENERATION OF CRISPR DETECTION
From molecular recognition to a readable answer.
Enter a section command or click its name to open that section.
clearUse ↑ and ↓ to recall commands. Tab completes a command. You can also click any command above.